Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Transplantation. 2021 Jan 1;105(1):170–176. doi: 10.1097/TP.0000000000003502

Figure 2. Changes in the use of lymphocyte-depleting agents and maintenance steroids during the COVID-19 pandemic; subgroup analyses.

Figure 2.

Figure 2.

(a) Lymphocyte-depleting agents (vs. nondepleting agent or no induction). (b) Maintenance steroids (vs. early steroid withdrawal).